Successful treatment of serpiginous choroiditis with alkylating agents

Ophthalmology

Volumn 109, Issue 8, 2002, Pages 1506-1513

  Akpek, Esen Karamursel ^a   Jabs, Douglas A ^a,b,c   Tessler, Howard H ^d   Joondeph, Brian C ^e   Foster, C Stephen ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

ADULT; AGED; ALKYLATION; ARTICLE; BLADDER CARCINOMA; BONE MARROW SUPPRESSION; CHOROIDITIS; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; FATIGUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LONG TERM CARE; MALE; NAUSEA; PRIORITY JOURNAL; REMISSION; SECOND CANCER; STEROID THERAPY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CHLORAMBUCIL; CHOROIDITIS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036342876     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01097-7     Document Type: Article

References (41)

1. Seltene augenspiegelbilder zum klinischen phänomen der retinitis exsudativa coats und der retino-choroiditis "parapapillaris."
2. Choroidal angio-sclerosis with special reference to its hereditary character
3. A curious affection of the fundus oculi: Helicoid peripapillar chorioretinal degeneration. Its relation to pigmentary paravenous chorioretinal degeneration
4. Geographic helicoid peripapillary choroidopathy
5. Serpiginous (geographic) choroiditis
6. Serpiginous choroiditis
7. Geographical choroidopathy
8. The clinical course of serpiginous choroidopathy
9. Subretinal neovascularization with geographic (serpiginous) choroiditis
10. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization
11. Failure of cyclosporin A in serpiginous choroiditis
12. Cyclosporine-A in the treatment of serpiginous choroiditis
13. Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome
14. Long-term immunosuppressive treatment of serpiginous choroiditis
15. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation
16. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease
17. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel
18. A follow-up study on serpiginous choroiditis
19. Serpiginous choroiditis
20. Subretinal and disc neovascularisation in serpiginous choroiditis
21. Unusual findings in serpiginous choroiditis
22. Triple agent immunosuppression in serpiginous choroiditis
23. Alkylating agents and platinum antitumor compounds
24. Immunosuppressive treatment of Behçet's disease with cyclophosphamide
25. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
26. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy
27. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus
28. Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man
29. Treatment of Behçet's disease with chlorambucil
30. Long-lasting remission of Behçet's disease after chlorambucil therapy
31. The use of chlorambucil in intractable idiopathic uveitis
32. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease
33. Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide
34. Second malignant neoplasms associated with immunosuppressive medications
35. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases
36. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study
37. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease
38. Wegener granulomatosis; an analysis of 158 patients